Uniqure NV (QURE)

Uniqure NV (QURE) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.6B; returns 1 day -2.9%, 1 week +3.0%, 1 year -62.2%.

uniQure N.V. (QURE) is a clinical-stage biotechnology company specializing in developing one-time gene therapies using AAV5 vectors for severe neurological and neuromuscular diseases. Its primary revenue streams are limited, derived from collaboration agreements, milestone payments, and grants rather than product sales, as it remains pre-commercial.

Groups QURE belongs to

• Biotechnology
• Gene Therapy
• Clinical Stage Biotech
• Healthcare
• Clinical Stage
• Neurological Disorders
• Rare Diseases
• Neuroscience
• Life Sciences
• Biopharmaceutical
• Biologics

QURE financial model: income statement, cash flow and balance sheet